Dialysis

American Kidney Fund Awards Fellowships to Researchers Studying Acute Interstitial Nephritis and Pulmonary Hypertension in Kidney Patients

Retrieved on: 
Thursday, April 11, 2024
Urine, Kidney disease, Cancer, Biomedical sciences, Inflammation, Biostatistics, MD–PhD, Kidney, Research fellow, Pulmonary hypertension, Nephritis, Risk, Hope, Blood, Clinical scientist, Epidemiology, Death, Immunotherapy, Clinical and Translational Science, MD, Research, Yale University, CSN, CKD, American Kidney Fund, Patient, Kidney transplantation, Bachelor of Arts, Dialysis, AKF, Diagnosis, Immune system, Chronic kidney disease, Heart failure, Pharmaceutical industry

However, it is common in patients with CKD, with approximately 21% of CKD patients having pulmonary hypertension.

Key Points: 
  • However, it is common in patients with CKD, with approximately 21% of CKD patients having pulmonary hypertension.
  • "Pulmonary hypertension is a common and underrecognized issue for patients with chronic kidney disease,” said Dr. Tuttle.
  • “Through this study, I plan to identify new risk factors for pulmonary hypertension in patients with chronic kidney disease.
  • Her current research focuses on the development of pulmonary hypertension in patients with chronic kidney disease.

Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Retrieved on: 
Friday, April 19, 2024
General Health, Health Technology, Health, Medical Devices, Dialysis, Medicine

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024.

Key Points: 
  • Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024.
  • On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.
  • The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, May 8, 2024.
  • A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/ .

Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.

Retrieved on: 
Wednesday, April 17, 2024
Biotechnology, Health Technology, Health, Medical Devices, Patient, Caregiver, Dialysis, ESKD, Kidney disease, Water, Medicine

Under the multi-year agreement, U.S. Renal Care can utilize Outset’s Tablo Hemodialysis System as a home dialysis option throughout the 33 states in which it provides care.

Key Points: 
  • Under the multi-year agreement, U.S. Renal Care can utilize Outset’s Tablo Hemodialysis System as a home dialysis option throughout the 33 states in which it provides care.
  • Patients dialyzing with Tablo report that the system is easy to learn and operate in their home.
  • Expanding treatment options in the communities served by U.S. Renal Care will aid in meeting the growing demand of dialysis patients seeking treatment at home.
  • "Our collaboration with U.S Renal Care is an important step forward in providing dialysis patients with options for where, when and how they want to dialyze.” said Leslie Trigg, Chair and CEO of Outset Medical.

Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States

Retrieved on: 
Wednesday, April 17, 2024
Medical Supplies, Managed Care, Other Health, Diabetes, Health, General Health, Transport, Health Technology, Medical Devices, Hospitals, Logistics, Supply Chain Management, Kidney disease, Marketing, Senior, Rockwell Medical, Patient, Chronic kidney disease, Dialysis, The Company

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it entered into a product purchase agreement with one of the largest health systems in the Mountain West region of the United States.

Key Points: 
  • Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it entered into a product purchase agreement with one of the largest health systems in the Mountain West region of the United States.
  • Under the terms of the agreement, Rockwell Medical will supply this health system with the Company's liquid and dry acid and bicarbonate hemodialysis concentrates, cleaning agents, hemodialysis concentrates mixers and any additional products offered by Rockwell Medical.
  • "We are proud to be a part of this health system's efforts to ensure patients with chronic kidney disease and end-stage renal disease receive a cutting-edge, fully integrated and coordinated experience throughout their continuum of kidney care," said Tim Chole , Senior Vice President, Sales and Marketing at Rockwell Medical.
  • "By further expanding our distribution capabilities to support this and other dialysis providers within the Mountain West region of the United States, we know that our hemodialysis portfolio of products will continue to have an impact on a broader patient population."

Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial

Retrieved on: 
Tuesday, April 16, 2024
Software, Seniors, Health, Data Management, Health Technology, Technology, Consumer, Clinical Trials, ROI, USRC, Drug, MD, Doctor of Philosophy, Consent, Research, Kidney disease, Signature, Translation, SVP, ESKD, Patient, Dialysis, Paper, Clinical trial, Associate, Ageing

Medable Inc. , the leading technology provider for modern clinical trials, achieved an impressive 75% adoption of its Total Consent solution deployed in elderly patient population in U.S. Renal Care ’s (USRC) investigator-initiated trial.

Key Points: 
  • Medable Inc. , the leading technology provider for modern clinical trials, achieved an impressive 75% adoption of its Total Consent solution deployed in elderly patient population in U.S. Renal Care ’s (USRC) investigator-initiated trial.
  • “Medable Total Consent helped us to rapidly launch and successfully recruit for a large multisite clinical trial and thoroughly consent a traditionally technology-averse demographic,” said Geoffrey A.
  • Block, MD, Associate Chief Medical Officer and SVP of Clinical Research and Medical Affairs at U.S. Renal Care.
  • Another study of the consenting process of 35 clinical trials (representing 13,200+ participants) found patients using eConsent versus paper had a better understanding of the trial information.

Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024

Retrieved on: 
Tuesday, April 16, 2024
Medical Devices, Medical Supplies, Hospitals, Diabetes, Health Technology, Other Health, Managed Care, Health, General Health, Webcast, Rockwell Medical, Dialysis, The Company

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the first quarter ended March 31, 2024 on Tuesday, May 14, 2024.

Key Points: 
  • Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the first quarter ended March 31, 2024 on Tuesday, May 14, 2024.
  • The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.

Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care

Retrieved on: 
Monday, April 15, 2024
Medical Devices, Other Health, Health, Health Technology, Nursing, Kidney disease, Nephrology, Policy, Kidney failure, RNS, American Journal, ANNA, Partnership, Chronic kidney disease, CKD, Patient, Dialysis, Medicine, Kidney, Chair

This collaboration underscores Outset’s dedication to supporting the nephrology nursing community and improving patient care in the realm of kidney disease.

Key Points: 
  • This collaboration underscores Outset’s dedication to supporting the nephrology nursing community and improving patient care in the realm of kidney disease.
  • Leslie Trigg, Chair and CEO of Outset, shared her thoughts on the partnership: “We enthusiastically support ANNA’s goal of empowering and educating nephrology nurses who are essential to delivering high-quality care to patients with kidney disease.
  • This partnership demonstrates our dedication to enhancing patient outcomes and supporting the vital role of the nephrology nurses who care for them.”
    ANNA emphasized the importance of collaboration with industry leaders to advance the nephrology nursing field.
  • “Outset Medical’s support, together with our other corporate partners, is important to our mission,” said Michele Kimball, ANNA Executive Director.

Dialysis Patient Citizens Issues Statement on Passing of Congressman Donald Payne Jr.

Retrieved on: 
Wednesday, April 24, 2024
Congress, ESRD, Health, Insurance, DPC, Kidney disease, Dialysis, Patient, Pleasure, Multimedia, Dialysis Patient Citizens

WASHINGTON, April 24, 2024 /PRNewswire/ -- Today, Dialysis Patient Citizens (DPC) Board President Andrew Conkling issued the following statement on the passing of Rep. Donald Payne Jr. (D-NJ). Rep. Payne received dialysis treatment, advocated for better care and insurance coverage for dialysis patients, and spoke at a DPC advocacy event in Washington, DC.

Key Points: 
  • WASHINGTON, April 24, 2024 /PRNewswire/ -- Today, Dialysis Patient Citizens (DPC) Board President Andrew Conkling issued the following statement on the passing of Rep. Donald Payne Jr. (D-NJ).
  • Rep. Payne received dialysis treatment, advocated for better care and insurance coverage for dialysis patients, and spoke at a DPC advocacy event in Washington, DC.
  • "We are deeply saddened to learn of the passing of Congressman Payne, who was a true friend to Dialysis Patient Citizens and a tireless advocate for dialysis patients across the country," said DPC Board President Andrew Conkling.
  • "Despite his ongoing health challenges, including end-stage renal disease (ESRD), Congressman Payne made the time and effort to fight for dialysis patients like himself.

First-Ever Combined Heart Pump and Pig Kidney Transplant Gives New Hope to Patient with Terminal Illness

Retrieved on: 
Wednesday, April 24, 2024
Kidney disease, Kidney, Hope, Heart, Love, NYU Langone Health, Doctor of Philosophy, Nursing, Family, Transplant, Dialysis, Physician, Surgeon, Heart failure, Dentistry

NEW YORK, April 24, 2024 /PRNewswire/ -- Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman with heart and kidney failure—a confluence of advances that showcase the possibility and hope of modern medicine.

Key Points: 
  • NEW YORK, April 24, 2024 /PRNewswire/ -- Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman with heart and kidney failure—a confluence of advances that showcase the possibility and hope of modern medicine.
  • Doctors performed this feat in two stages: first surgically implanting the heart pump days before embarking on the landmark transplant, which included a gene-edited pig kidney and the pig's thymus gland to aid against rejection.
  • Before the procedure, patient Lisa Pisano, a New Jersey native, faced heart failure and end-stage kidney disease that required routine dialysis.
  • It is only the second known transplant of a gene-edited pig kidney into a living person, and the first with the thymus combined.

Premier Healthcare Holdings Inc. Names Buffy Stultz White as CEO

Retrieved on: 
Tuesday, April 23, 2024
Travel nursing, MSP, Health care, SIA, Growth, White, Dialysis, PHHI, Multimedia, PHP, Woman, Nursing

CUMMING, Ga., April 23, 2024 /PRNewswire/ -- Premier Healthcare Holdings, Inc. (PHHI), a private company, announced it has named healthcare industry veteran Buffy Stultz White as CEO to lead the next phase of growth.

Key Points: 
  • CUMMING, Ga., April 23, 2024 /PRNewswire/ -- Premier Healthcare Holdings, Inc. (PHHI), a private company, announced it has named healthcare industry veteran Buffy Stultz White as CEO to lead the next phase of growth.
  • Premier Healthcare Holdings, Inc. has named healthcare industry veteran Buffy Stultz White as CEO.
  • "I am honored to join PHHI, a diversified and highly respected organization that is committed to making positive impacts and a difference in the healthcare industry," said Buffy Stultz White, CEO.
  • Headquartered in Cumming, Georgia, Premier Healthcare Holdings, Inc. (PHHI), is a private holding company that owns and oversees the operations of six healthcare organization subsidiaries: Premier Healthcare Professionals (PHP), Adevia Health USA , Freedom Crisis Staffing , Freedom Healthcare Staffing , Corratel Healthcare and Renal Reserve .